---

$18.92

-0.7650 ( -3.89% ) 331.9K

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-06-03	Buy	5000.00	BIENAIME JEAN JACQUES
2024-11-25	Buy	66057.00	SIEGALL CLAY B
2024-11-25	Buy	15805.00	Lechleider Robert
2024-11-25	Buy	21000.00	Tsai Philip
2024-08-19	Buy	7000.00	BIENAIME JEAN JACQUES
2024-08-13	Sale	-190000.00	Rosett Max
2024-08-13	Sale	-110000.00	Turner Bruce
2024-08-13	Sale	-200000.00	Lechleider Robert
2024-08-13	Sale	-190000.00	Higgins Jack
2024-08-13	Sale	-210000.00	Stoneman Sandra G.